| Literature DB >> 23892902 |
Masafumi Eguchi1, Masanori Ohta, Hiroshi Yamato.
Abstract
The aim of this study was to determine whether accumulated short bouts of exercise can achieve the same cardiovascular benefits as a single long bout of exercise in sedentary male Japanese workers and to compare the programs' relative effects on oxidative stress. Twenty-three sedentary male workers were randomly assigned into 2 different exercise programs: a Long-bout group, which performed a single period of continuous exercise (Long-bout group: 30 min × 1) 3 d per week, and a Short-bouts group, which performed 3 short bouts of exercise (Short-bouts group: 10 min × 3) 3 d per week. Cardiovascular risk factors, including the plasma thiobarbituric acid-reactive substances (TBARS) level, were examined at baseline and after both 10 and 20 wk. In the Long-bout group, waist circumference and maximum oxygen uptake (VO2max) significantly improved after 20 wk. The Short-bouts group demonstrated significant increases in VO2max after 10 weeks and in HDL-C after 20 wk. Plasma TBARS significantly decreased after 20 weeks in the Long-bout group and tended to decrease (but not significantly) in the Short-bouts group. These results indicate that accumulated short bouts of exercise are an effective option, especially for busy workers, for incorporating exercise into one's lifestyle.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23892902 PMCID: PMC4202748 DOI: 10.2486/indhealth.2013-0023
Source DB: PubMed Journal: Ind Health ISSN: 0019-8366 Impact factor: 2.179
Fig. 1.Flowchart for participants.
Baseline characteristics
| Short-bouts, n=12, mean ± SD | Long-bout , n=11, mean ± SD | |||||
|---|---|---|---|---|---|---|
| Age (yr) | 43.3 ± 12.4 | (27–63) | 44.5 ± 11.1 | (27–59) | 0.822 | |
| SBP (mm Hg) | 122.5 ± 11.2 | (105.3–140.6) | 118.6 ± 8.9 | (104.3–131.7) | 0.374 | |
| DBP (mm Hg) | 77.5 ± 6.8 | (67.0–89.7) | 75.1 ± 6.1 | (67.0–85.0) | 0.370 | |
| PR (bpm) | 76.8 ± 12.4 | (60.3–115.7) | 73.7 ± 12.4 | (60.0–90) | 0.567 | |
| BW (kg) | 74.1 ± 8.5 | (59.7–87.0) | 73.3 ± 11.4 | (57.5–89.7) | 0.856 | |
| BMI (kg·m–2) | 26 ± 2.4 | (22.7–32.0) | 25.6 ± 3.9 | (20.8–32.1) | 0.760 | |
| Waist circumference (cm) | 89.5 ± 5.1 | (83.5–101.2) | 89.9 ± 7.6 | (79.8–99.4) | 0.895 | |
| V·O2max (mL·kg–1·min–1)a | 35.1 ± 4.5 | (26.6–46.4) | 38 ± 7.5 | (29.8–53.3) | 0.280 | |
| TC (mg·dL–1) | 212.8 ± 32.4 | (169–281) | 201.5 ± 20 | (167–234) | 0.331 | |
| HDL-C (mg·dL–1) a | 51.8 ± 13.9 | (33–81) | 47.5 ± 9.2 | (38–62) | 0.451 | |
| TG (mg·dL–1) a | 150.4 ± 82.5 | (66–356) | 143.1 ± 79.4 | (74–348) | 0.787 | |
| LDL-C (mg·dL–1) | 130.8 ± 29.5 | (92.8–176.2) | 125.3 ± 27.1 | (71.4–159.2) | 0.645 | |
| FPI (μU·mL–1) a | 8.9 ± 3.6 | (3.4–16.4) | 7.7 ± 3 | (2.4–13.8) | 0.449 | |
| FPG (mg·dL–1) a | 124.7 ± 46.1 | (96–266) | 100.5 ± 7.1 | (91–112) | 0.049 | |
| HOMA-IR a | 2.64 ± 1.00 | (0.81–4.41) | 1.95 ± 0.9 | (0.54–3.82) | 0.127 | |
| TBARS (μmol·L–1) a | 0.28 ± 0.05 | (0.20–0.36) | 0.28 ± 0.05 | (0.22–0.37) | 0.999 | |
| Smoking | 0.465 | |||||
| Current smoker | 1 | 0 | ||||
| Ex-smoker | 5 | 4 | ||||
| Non-smoker | 6 | 7 | ||||
| Alcohol consumption | 0.901 | |||||
| Almost every day | 9 | 8 | ||||
| Occasional drinker | 3 | 3 | ||||
| Medication | – | |||||
| Antihypertensive agent | 3 | 2 | ||||
| Oral anti-diabetes agent | 1 | 0 | ||||
| Lipid-lowering agent | 0 | 1 | ||||
| Type of a Job | 0.509 | |||||
| Researcher | 6 | 7 | ||||
| Clerical worker | 6 | 4 | ||||
Short-bouts = three 10-min exercises d–1 on 3 d week–1; Long-bout = 30-min exercises d–1 on 3 d weeks–1.
SBP: systolic blood pressure, DBP: diastolic blood pressure, PR: pulse rate, BW: body weight, BMI: body mass index, V·O2max: maximum oxygen uptake, TC: total cholesterol, HDL-C: high-density lipoprotein cholesterol, TG: triglyceride, LDL-C: low-density lipoprotein cholesterol, FPI: fasting plasma insulin, FPG: fasting plasma glucose, HOMA-IR: Homeostasis model assessment of insulin resistance, TBARS: thiobarbituric acid reactive substances. a: for analyses these continuous values were log-transformed. b: p for unpaired t-test or χ2 test.
Changes in anthropometric measures, blood pressure, predicted maximum oxygen uptake, and glucose and lipid metabolism of subjects from pre- (baseline) to mid- (10 wk) and post- (20 wk) training for the long-bout and short-bouts groups
| Short-bouts (n=12) | Long-bout (n=11) | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10 wk-baseline | ES ( | 20 wk-baseline | ES ( | 10 wk-baseline | ES ( | 20 wk-baseline | ES ( | ES ( | ES ( | ||||||||||
| Δ SBP (mm Hg) | 2.6 ± 7.1 | 0.229 | 0.37 | 9.6 ± 10.5 | 0.009 | 0.91 | 1 ± 7.9 | 0.683 | 0.13 | 0.7 ± 11.3 | 0.843 | 0.06 | 0.109 | 0.50 | 0.183 | 0.39 | |||
| Δ DBP (mm Hg) | 3.2 ± 4.3 | 0.024 | 0.74 | 8.1 ± 7.4 | 0.023 | 1.09 | 2.1 ± 2.6 | 0.023 | 0.81 | 1.8 ± 6.2 | 0.368 | 0.29 | 0.004 | 0.87 | 0.111 | 0.44 | |||
| Δ PR (bpm) | –3.5 ± 11.8 | 0.329 | 0.30 | –5.7 ± 21 | 0.372 | 0.27 | –0.8 ± 7.8 | 0.742 | 0.10 | –1.4 ± 12.9 | 0.717 | 0.11 | 0.611 | 0.22 | 0.674 | 0.19 | |||
| Δ BW (kg) | –0.15 ± 1.3 | 0.698 | 0.12 | –0.48 ± 2.86 | 0.57 | 0.17 | –0.62 ± 1.28 | 0.14 | 0.48 | –0.49 ± 1.71 | 0.363 | 0.29 | 0.396 | 0.31 | 0.551 | 0.20 | |||
| Δ BMI (kg·m–2) | –0.05 ± 0.47 | 0.719 | 0.11 | –0.22 ± 1.03 | 0.471 | 0.21 | –0.28 ± 0.49 | 0.088 | 0.57 | –0.23 ± 0.71 | 0.301 | 0.32 | 0.297 | 0.36 | 0.336 | 0.43 | |||
| Δ Waist (cm) | –0.66 ± 1.63 | 0.19 | 0.40 | –1.31 ± 3.3 | 0.196 | 0.40 | –1.41 ± 2.25 | 0.065 | 0.63 | –2.19 ± 2.47 | 0.015 | 0.89 | 0.033 | 0.64 | 0.672 | 0.20 | |||
| Δ Ln V·O2max(mL·kg–1·min–1)a | 0.024 ± 0.036 | 0.042 | 0.67 | 0.065 ± 0.118 | 0.083 | 0.55 | 0.055 ± 0.072 | 0.03 | 0.76 | 0.073 ± 0.081 | 0.014 | 0.90 | 0.007 | 0.88 | 0.558 | 0.00 | |||
| ΔTC (mg·dL–1) | –1.5 ± 19.6 | 0.796 | 0.08 | 2.9 ± 18.3 | 0.593 | 0.16 | –0.3 ± 10.1 | 0.931 | 0.03 | 1.2 ± 16.7 | 0.819 | 0.07 | 0.786 | 0.16 | 0.942 | 0.08 | |||
| Δ Ln HDL-C (mg·dL–1)a | 0.013 ± 0.105 | 0.679 | 0.12 | 0.083 ± 0.118 | 0.034 | 0.70 | –0.044 ± 0.103 | 0.192 | 0.43 | 0.036 ± 0.093 | 0.228 | 0.39 | 0.003 | 0.96 | 0.291 | 0.00 | |||
| Δ Ln TG (mg·dL–1)a | –0.005 ± 0.267 | 0.952 | 0.02 | –0.163 ± 0.421 | 0.208 | 0.39 | –0.074 ± 0.437 | 0.583 | 0.17 | –0.122 ± 0.238 | 0.119 | 0.51 | 0.209 | 0.44 | 0.424 | 0.16 | |||
| ΔLDL-C (mg·dL–1) | –2.4 ± 21 | 0.698 | 0.11 | 4.1 ± 23 | 0.546 | 0.18 | 6 ± 15.6 | 0.229 | 0.38 | 3.3 ± 14.6 | 0.477 | 0.23 | 0.678 | 0.20 | 0.412 | 0.29 | |||
| Δ Ln FPI (μU·mL–1)a | –0.079 ± 0.253 | 0.306 | 0.31 | 0.001 ± 0.377 | 0.995 | 0.00 | 0.082 ± 0.391 | 0.505 | 0.16 | 0.055 ± 0.381 | 0.643 | 0.01 | 0.926 | 0.09 | 0.502 | 0.18 | |||
| Δ Ln FPG (mg·dL–1)a | –0.044 ± 0.086 | 0.106 | 0.51 | –0.007 ± 0.065 | 0.729 | 0.11 | 0.003 ± 0.049 | 0.86 | 0.06 | 0.005 ± 0.069 | 0.831 | 0.07 | 0.416 | 0.33 | 0.365 | 0.31 | |||
| Δ Ln HOMA-IRa | –0.122 ± 0.255 | 0.126 | 0.48 | –0.006 ± 0.387 | 0.959 | 0.02 | 0.084 ± 0.411 | 0.513 | 0.20 | 0.059 ± 0.425 | 0.653 | 0.14 | 0.816 | 0.14 | 0.322 | 0.34 | |||
| Δ Ln TBARS (μmol·L–1) a | –0.006 ± 0.09 | 0.82 | 0.07 | –0.071 ± 0.123 | 0.071 | 0.58 | –0.059 ± 0.111 | 0.112 | 0.53 | –0.085 ± 0.124 | 0.047 | 0.69 | 0.011 | 0.71 | 0.208 | 0.30 | |||
Short-bouts = three 10-min exercises d–1 on 3 d week–1; Long-bout = 30-min exercises d–1 on 3 d weeks–1. SBP: systolic blood pressure, DBP: diastolic blood pressure, PR; pulse rate, BW: body weight, BMI: body mass index, V·O2max: maximum oxygen uptake, TC: total cholesterol, HDL-C: high-density lipoprotein cholesterol, TG: triglyceride, LDL-C: low-density lipoprotein cholesterol, FPI: fasting plasma insulin, FPG: fasting plasma glucose, HOMA-IR: Homeostasis model assessment of insulin resistance, TBARS: thiobarbituric acid reactive substances, ES: effect size (these values represent as absolute values). The thresholds for small, medium, and large effects were defined as d values below 0.20, 0.50, and 0.80; f values below 0.10, 0.25, and 0.40; and f values below 0.02, 0.15, and 0.35, respectively. a: for analyses there values were log-transformed. b: p for paired t-test, versus baseline. c: p for MANOVA.